These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9097987)

  • 41. Expression of intercellular adhesion molecule-1 (ICAM-1) on renal-cell cancer: possible significance in host immune responses.
    Tomita Y; Nishiyama T; Watanabe H; Fujiwara M; Sato S
    Int J Cancer; 1990 Dec; 46(6):1001-6. PubMed ID: 1979067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation.
    Brasanac D; Müller CA; Müller GA; Hadzi-Dzokic J; Markovic-Lipkovski J
    J Exp Clin Cancer Res; 1999 Dec; 18(4):505-10. PubMed ID: 10746977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of HLA-DR and invariant chain expression by human peripheral blood mononuclear cells with lead, interferon-gamma, or interleukin-4.
    Guo TL; Mudzinski SP; Lawrence DA
    Cell Immunol; 1996 Jul; 171(1):1-9. PubMed ID: 8660831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
    Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
    Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
    Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
    Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapies.
    Bukur J; Seliger B
    Semin Cancer Biol; 2003 Oct; 13(5):353-9. PubMed ID: 14708715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes.
    Schleypen JS; Von Geldern M; Weiss EH; Kotzias N; Rohrmann K; Schendel DJ; Falk CS; Pohla H
    Int J Cancer; 2003 Oct; 106(6):905-12. PubMed ID: 12918068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human renal-cell carcinoma cells are able to activate natural killer cells.
    Hayakawa K; Morita T; Augustus LB; von Eschenbach AC; Itoh K
    Int J Cancer; 1992 May; 51(2):290-5. PubMed ID: 1533204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer.
    Tomita Y; Nishiyama T; Fujiwara M; Sato S
    Br J Cancer; 1990 Sep; 62(3):354-9. PubMed ID: 2206942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of HLA-G expression in renal cell carcinoma.
    Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
    Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines.
    Lin X; Wang X; Capek HL; Simone LC; Tuli A; Morris CR; Reber AJ; Solheim JC
    Cancer Immunol Immunother; 2009 May; 58(5):729-36. PubMed ID: 18828016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
    Carrel S; Schmidt-Kessen A; Giuffrè L
    Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immunological study on renal cell carcinoma in dialysis patients with acquired cystic disease of kidneys].
    Onishi T; Machida T; Masuda F; Torii S; Shirakawa H; Hatano T; Makino H
    Nihon Hinyokika Gakkai Zasshi; 1991 Nov; 82(11):1800-6. PubMed ID: 1762269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunomorphological characteristics of renal cell carcinoma.
    Markovic-Lipkovski J; Brasanac D; Todorovic V; Müller CA; Müller GA
    Histol Histopathol; 1995 Jul; 10(3):651-9. PubMed ID: 7579814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
    Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunophenotypic markers in renal cell carcinoma.
    Banner BF; Burnham JA; Bahnson RR; Ernstoff MS; Auerbach HE
    Mod Pathol; 1990 Mar; 3(2):129-34. PubMed ID: 1691492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients.
    Whitford P; George WD; Campbell AM
    Cancer Lett; 1992 Jan; 61(2):157-64. PubMed ID: 1730139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Localization of IFN-gamma receptor in first trimester placenta to trophoblasts but lack of stimulation of HLA-DRA, -DRB, or invariant chain mRNA expression by IFN-gamma.
    Peyman JA; Hammond GL
    J Immunol; 1992 Oct; 149(8):2675-80. PubMed ID: 1401907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invariant chain expression in colon neoplasms.
    Jiang Z; Xu M; Savas L; LeClair P; Banner BF
    Virchows Arch; 1999 Jul; 435(1):32-6. PubMed ID: 10431843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Invariant chain expression in gastric cancer.
    Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Iwashige H; Aridome K; Hokita S; Aikou T
    Cancer Lett; 2001 Jul; 168(1):87-91. PubMed ID: 11368882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.